☆ 4.7 Letter

OXA-72-producing Acinetobacter baumannii in Brazil: a case report

JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2011)

期刊

JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

卷 66, 期 2, 页码 452-454

出版社

OXFORD UNIV PRESS

DOI: 10.1093/jac/dkq462

关键词

beta-lactam resistance; carbapenemases; OXA-24-like; ampicillin; sulbactam

类别

Infectious Diseases Microbiology Pharmacology & Pharmacy

向作者/读者索取更多资源

Protocol

Reagent

作者

我是这篇论文的作者

点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7

评分不足

次要评分

新颖性

-

重要性

-

科学严谨性

-

评价这篇论文

推荐

Article Medicine, Research & Experimental

Evaluation of continuous ampicillin/sulbactam infusion in critically ill patients

S. G. Passon, A. R. Schmidt, M. Wittmann, M. Velten, T. Baehner

Summary: Continuous infusion of ampicillin/sulbactam in critically ill patients showed therapeutic concentrations exceeding the minimum inhibitory concentration (MIC) breakpoint in all measurements and above the 4-fold MIC in the majority of analyses. However, patients with acute kidney injury had significantly higher serum concentrations, while impaired renal function and increased renal clearance affected drug levels.

LIFE SCIENCES (2023)

添加到收藏夹

Article Microbiology

A Whole-Genome Sequencing-Based Approach for the Characterization of Klebsiella pneumoniae Co-Producing KPC and OXA-48-like Carbapenemases Circulating in Sardinia, Italy

Arcadia Del Rio, Valeria Fox, Narcisa Muresu, Illari Sechi, Andrea Cossu, Alessandra Palmieri, Rossana Scutari, Claudia Alteri, Giovanni Sotgiu, Paolo Castiglia, Andrea Piana

Summary: This study used whole-genome sequencing to analyze carbapenemase-producing Klebsiella pneumoniae strains causing hospital-acquired infections, and identified multiple antibiotic resistance genes and porin mutations. The findings highlight the importance of genomic surveillance in hospital settings for monitoring the emergence of new clones and improving control and preventive strategies.

MICROORGANISMS (2023)

添加到收藏夹

Article Chemistry, Medicinal

Mechanistic Basis of OXA-48-like β-Lactamases' Hydrolysis of Carbapenems

Vlatko Stojanoski, Liya Hu, Banumathi Sankaran, Feng Wang, Peng Tao, B. V. Venkataram Prasad, Timothy Palzkill

Summary: Carbapenem-hydrolyzing class D beta-lactamases (CHDLs) confer resistance to carbapenem antibiotics, with OXA-48 and OXA-163 being members of the OXA-48-like enzyme group. OXA-163 displays altered substrate specificity compared to OXA-48, with decreased carbapenemase activity due to a slower deacylation reaction. Structural analysis suggests that differences in active site architecture contribute to the differences in carbapenem hydrolysis between OXA-48 and OXA-163.

ACS INFECTIOUS DISEASES (2021)

添加到收藏夹

Article Infectious Diseases

Effect of Blood Product Resuscitation on the Pharmacokinetics of Ampicillin-Sulbactam during Orthotopic Liver Transplantation

Maxwell J. Lasko, Oscar K. Serrano, Abigail K. Kois, David P. Nicolau, Joseph L. Kuti

Summary: The study found that high and frequent doses of ampicillin-sulbactam are needed to maintain target attainment rates during orthotopic liver transplant surgeries. Additionally, it was observed that blood product resuscitation does not impact ampicillin exposure in patients undergoing liver transplants.

SURGICAL INFECTIONS (2022)

添加到收藏夹

Article Microbiology

OXA-484, an OXA-48-Type Carbapenem-Hydrolyzing Class D β-Lactamase From Escherichia coli

Julian Sommer, Kristina M. Gerbracht, Felix F. Krause, Florian Wild, Manuela Tietgen, Sara Riedel-Christ, Janko Sattler, Axel Hamprecht, Volkhard A. J. Kempf, Stephan Goettig

Summary: The study identified OXA-484 as a carbapenemase with high sequence similarity plasmids, showing low frequency in horizontal gene transfer. OXA-484 exhibits antibiotic activity between OXA-232 and OXA-244, demonstrating unique resistance characteristics.

FRONTIERS IN MICROBIOLOGY (2021)

添加到收藏夹

Article Biochemistry & Molecular Biology

Specific Amino Acid Substitutions in OXA-51-Type β-Lactamase Enhance Catalytic Activity to a Level Comparable to Carbapenemase OXA-23 and OXA-24/40

Kwan-Wai Chan, Chen-Yu Liu, Ho-Yin Wong, Wai-Chi Chan, Kwok-Yin Wong, Sheng Chen

Summary: This study aimed to investigate the effect of key amino acid substitutions in OXA-51 variants of carbapenem-hydrolyzing class D beta-lactamases (CHDLs) on substrate catalysis. Mutational and structural analyses revealed that specific amino acid substitutions can increase catalytic activity, with the I129L mutation having the most significant effect. Additionally, the combination of W222G and I129L substitutions in OXA-66 showed a strong catalytic enhancement effect, surpassing other variants in activity against carbapenems. The blaO(XA-51) gene in Acinetobacter baumannii is likely to continue evolving, generating mutant genes that encode carbapenemase with extremely strong catalytic activity.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2022)

添加到收藏夹

Article Critical Care Medicine

The clinical and paraclinical effectiveness of four-hour infusion vs. half-hour infusion of high-dose ampicillin-sulbactam in treatment of critically ill patients with sepsis or septic shock: An assessor-blinded randomized clinical trial

Mahtabalsadat Mirjalili, Farid Zand, Iman Karimzadeh, Mansoor Masjedi, Golnar Sabetian, Ehsan Mirzaei, Afsaneh Vazin

Summary: This study compared the efficacy of extended infusion and intermittent infusion of ampicillin/sulbactam in the treatment of sepsis and septic shock patients in the ICU. The results showed that the extended group had significantly higher clinical cure rates, while there were no significant differences in ICU and hospital length of stay. Additionally, the ICU and hospital mortality rates were significantly lower in the extended infusion group.

JOURNAL OF CRITICAL CARE (2023)

添加到收藏夹

Article Chemistry, Medicinal

Unique Diacidic Fragments Inhibit the OXA-48 Carbapenemase and Enhance the Killing of Escherichia coli Producing OXA-48

Doris Mia Taylor, Justin Anglin, Liya Hu, Lingfei Wang, Banumathi Sankaran, Jin Wang, Martin M. Matzuk, B. V. Venkataram Prasad, Timothy Palzkill

Summary: This study screened various low-molecular-weight compounds against OXA-48 and identified functional scaffolds for inhibitor development with key interactions revealed. Some low-micromolar-potency inhibitors synergize with ampicillin to kill Escherichia coli expressing OXA-48, albeit at high concentrations of the respective inhibitors. Additionally, several compounds showed micromolar potency toward OXA-24 and OXA-58 class D carbapenemases prevalent in Acinetobacter baumannii.

ACS INFECTIOUS DISEASES (2021)

添加到收藏夹

Article Microbiology

In Vitro Activity of Two Cefepime-Based Novel Combinations, Cefepime/Taniborbactam and Cefepime/Zidebactam, against Carbapenemase-Expressing Enterobacterales Collected in India

Yamuna Devi Bakthavatchalam, Divyaa Elangovan, Subha Vajjiravelu Jaganathan, Nivedhana Subburaju, Abirami Shankar, Yuvasri Manokaran, J. Sudarsana, Rema Devi, Sujata Baveja, Sheela Devi, S. Jayakumar, Sanjay Bhattacharya, S. M. Rudresh, Bineshlal Yesudhason, Vignesh Shetty, Ankur Mutreja, Abi Manesh, George M. M. Varghese, Charis A. A. Marwick, Benjamin J. J. Parcell, Ian H. H. Gilbert, Balaji Veeraraghavan

Summary: The study revealed the differential ability of cefepime/taniborbactam and cefepime/zidebactam in tackling carbapenemase-producing Indian clinical isolates that also harbored additional mechanisms of resistance. NDM-expressing E. coli with 4-amino-acid insert in PBP3 are predominately resistant to cefepime/taniborbactam, while the beta-lactam enhancer mechanism-based cefepime/zidebactam showed consistent activity against single- or dual-carbapenemase-producing isolates including E. coli with PBP3 inserts.

MICROBIOLOGY SPECTRUM (2023)

添加到收藏夹

Article Infectious Diseases

Sulbactam Enhances in vitro Activity of β-Lactam Antibiotics Against Acinetobacter baumannii

Leilei Wang, Yuancheng Chen, Renru Han, Zhiwei Huang, Xuefei Zhang, Fupin Hu, Fan Yang

Summary: The study demonstrated that increasing the proportion of sulbactam could enhance the antimicrobial activities of three beta-lactam antibiotics combined with sulbactam against Acinetobacter baumannii clinical strains in China, with cefoperazone-sulbactam showing the highest efficacy.

INFECTION AND DRUG RESISTANCE (2021)

添加到收藏夹

Article Infectious Diseases

Characterization of the novel OXA-213-like beta-lactamase OXA-822 from Acinetobacter calcoaceticus

Manuela Tietgen, Laura Leukert, Julian Sommer, Jan S. Kramer, Steffen Brunst, Ilka Wittig, Ewgenij Proschak, Stephan Goettig

Summary: The study identified a novel carbapenem-hydrolysing class D beta-Lactamase OXA-822 in a clinical Acinetobacter calcoaceticus isolate, which displayed penicillinase and carbapenemase activity in vitro, elevated MICs in different species, and decreased carbapenem susceptibility in Acinetobacter baumannii in vivo.

JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2021)

添加到收藏夹

Article Immunology

Activity of Sulbactam-Durlobactam and Comparators Against a National Collection of Carbapenem-Resistant Acinetobacter baumannii Isolates From Greece

Dimitra Petropoulou, Maria Siopi, Sophia Vourli, Spyros Pournaras

Summary: This study evaluated the in vitro activity of the sulbactam-durlobactam (SD) combination against carbapenem-resistant A. baumannii isolates. SD demonstrated the lowest minimum inhibitory concentration (MIC90) and showed potential utility for the treatment of infections caused by A. baumannii. The addition of imipenem further enhanced the activity of SD.

FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY (2022)

添加到收藏夹

Article Infectious Diseases

Effect of sigma E on carbapenem resistance in OXA-48-producing Klebsiella pneumoniae

Martina Cremanns, Felix Lange, Soeren G. Gatermann, Niels Pfennigwerth

Summary: The study identified resistance mechanisms in Klebsiella pneumoniae with varying levels of resistance to carbapenems, mainly through mutations in ompK36 and the rpoE gene. These mutations affect bacterial resistance and growth rates, reducing the expression of major outer membrane proteins. Enhanced synthesis of sigma(E) leads to increased resistance to cephalosporins and carbapenems in clinical K. pneumoniae isolates, accompanied by a significant reduction in growth rates.

JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2022)

添加到收藏夹

Article Environmental Sciences

Bone Concentration of Ampicillin/Sulbactam: A Pilot Study in Patients with Osteonecrosis of the Jaw

Anton Straub, Maximilian Stapf, Markus Fischer, Andreas Vollmer, Christian Linz, Thien-Tri Lam, Alexander Kuebler, Roman C. Brands, Oliver Scherf-Clavel, Stefan Hartmann

Summary: Osteonecrosis of the jaw (ONJ), a common complication after head and neck irradiation or intake of antiresorptive agents, can lead to infection and necrosis due to compromised bone perfusion. Treatment typically involves surgical necrosectomy and prolonged antibiotics therapy. In this study, the concentration of antibiotics in plasma and bone samples was investigated, with relatively low concentrations found. However, these concentrations seem sufficient to kill most bacteria present in the biofilm of ONJ, suggesting that intravenous administration of ampicillin/sulbactam remains a valuable treatment for ONJ.

INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH (2022)

添加到收藏夹

Article Pharmacology & Pharmacy

Comparison of bleeding risk and hypofibrinogenemia-associated risk factors between tigecycline with cefoperazone/sulbactam therapy and other tigecycline-based combination therapies

Lei Zhang, Xinfeng Cai, Fangchen Peng, Shuangshuang Tian, Xinjing Wu, Yun Li, Jinlin Guo

Summary: This study investigated the risk of bleeding and hypofibrinogenemia associated with tigecycline plus cefoperazone/sulbactam compared to other tigecycline-based combination therapies. The results showed that all patients experienced prolonged clotting time and decreased fibrinogen levels after tigecycline-based medication, but there were no significant differences in bleeding events between the different treatment groups. Age, treatment duration, daily dose, total bilirubin, and basal fibrinogen were identified as independent risk factors for hypofibrinogenemia.

FRONTIERS IN PHARMACOLOGY (2023)

添加到收藏夹

Article Infectious Diseases

Comparison of ceftazidime-avibactam and ceftolozane-tazobactam in vitro activities when tested against gram-negative bacteria isolated from patients hospitalized with pneumonia in United States medical centers (2017-2018)

Helio S. Sader, Robert K. Flamm, Cecilia G. Carvalhaes, Mariana Castanheira

DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE (2020)

添加到收藏夹

Article Infectious Diseases

Antimicrobial activity of cefoperazone-sulbactam tested against Gram-Negative organisms from Europe, Asia-Pacific, and Latin America

Helio S. Sader, Cecilia G. Carvalhaes, Jennifer M. Streit, Mariana Castanheira, Robert K. Flamm

INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES (2020)

添加到收藏夹

Review Infectious Diseases

Clinical utilization of bacteriophages: a new perspective to combat the antimicrobial resistance in Brazil

Willames M. B. S. Martins, Mark A. Toleman, Ana C. Gales

BRAZILIAN JOURNAL OF INFECTIOUS DISEASES (2020)

添加到收藏夹

Article Infectious Diseases

Joint report of SBI (Brazilian Society of Infectious Diseases), FEBRASGO (Brazilian Federation of Gynecology and Obstetrics Associations), SBU (Brazilian Society of Urology) and SBPC/ML (Brazilian Society of Clinical Pathology/Laboratory Medicine): recommendations for the clinical management of lower urinary tract infections in pregnant and non-pregnant women

Patricia de Rossi, Sergio Cimerman, Jose Carlos Truzzi, Clovis Arns da Cunha, Rosiane Mattar, Marines Dalla Valle Martino, Mauricio Hachul, Adagmar Andriolo, Jose Ananias Vasconcelos Neto, Joao Antoio Pereira-Correia, Antonia M. O. Machado, Ana Cristina Gales

BRAZILIAN JOURNAL OF INFECTIOUS DISEASES (2020)

添加到收藏夹

Article Pharmacology & Pharmacy

Exposure to sub-inhibitory ciprofloxacin and nitrofurantoin concentrations increases recA gene expression in uropathogenic Escherichia coli: The role of RecA protein as a drug target

Aghata Cardoso da Silva Ribeiro, Willames Marcos Brasileiro da Silva Martins, Adilson Aderito da Silva, Ana Cristina Gales, Daniela Goncales Galasse Rando, Luciene Andrade da Rocha Minarini

EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES (2020)

添加到收藏夹

Letter Infectious Diseases

Detection of BKC-1 in Citrobacter freundii: A clue to mobilisation in an IncQ1 plasmid carrying blaBKC-1

Willames M. B. S. Martins, Bruna M. S. Seco, Jorge L. M. Sampaio, Kirsty Sands, Mark A. Toleman, Ana C. Gales

INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2020)

添加到收藏夹

Article Infectious Diseases

Dynamic of High-RiskAcinetobacter baumanniiMajor Clones in a Brazilian Tertiary Hospital During a Short Time Period

Bruno C. Boettger, Rodrigo Cayo, Ana Paula Streling, Carolina S. Nodari, Luiz G. P. Almeida, Willames M. B. S. Martins, Raquel Girardello, Ana Tereza R. Vasconcelos, Ana C. Gales, Antonio C. C. Pignatari

Summary: Distinct extensively drug-resistant A. baumannii clones can circulate in the same hospital setting during a short time period, illustrating a very complex epidemiological scenario for this priority pathogen.

MICROBIAL DRUG RESISTANCE (2021)

添加到收藏夹

Article Engineering, Environmental

Frequency and diversity of Stenotrophomonas spp. carrying blaKPC in recreational coastal waters

Stella Maria Casas Novas Mancano, Eloiza Helena Campana, Thais Pessanha Felix, Lina Rachel Leite Barrueto, Polyana Silva Pereira, Renata Cristina Picao

WATER RESEARCH (2020)

添加到收藏夹

Article Microbiology

Frequency and Diversity of Hybrid Escherichia coli Strains Isolated from Urinary Tract Infections

Jullia A. S. Nascimento, Fernanda F. Santos, Tiago B. Valiatti, Jose F. Santos-Neto, Ana Carolina M. Santos, Rodrigo Cayo, Ana C. Gales, Tania A. T. Gomes

Summary: This study identified 9 out of 452 UPEC strains (2%) as hybrid strains, with 7 classified as UPEC/EAEC and 2 as UPEC/aEPEC. These hybrid strains displayed specific characteristics in terms of cell adhesion ability and virulence potential.

MICROORGANISMS (2021)

添加到收藏夹

Article Microbiology

Prevalence of blaKPC-2, blaKPC-3 and blaKPC-30-Carrying Plasmids in Klebsiella pneumoniae Isolated in a Brazilian Hospital

Leticia B. Migliorini, Romario O. de Sales, Paula C. M. Koga, Andre M. Doi, Anja Poehlein, Alexandra R. Toniolo, Fernando G. Menezes, Marines D. Martino, Ana C. Gales, Holger Brueggemann, Patricia Severino

Summary: This study reports the genomic context of KPC coding genes bla(KPC-2), bla(KPC-3) and bla(KPC-30) in multidrug-resistant Klebsiella pneumoniae isolates from Brazil, with a focus on the prevalence and dissemination of bla(KPC)-harboring plasmids. It demonstrates the risk of horizontal spread of KPC coding genes and the high synteny of plasmid backbones among isolates, including the recent spread of bla(KPC-3) and bla(KPC-30).

PATHOGENS (2021)

添加到收藏夹

Article Infectious Diseases

Silent circulation of BKC-1-producing Klebsiella pneumoniae ST442: molecular and clinical characterization of an early and unreported outbreak

Willames M. B. S. Martins, Michael H. Lenzi, Ana C. Narciso, Priscila P. Dantas, Diego O. Andrey, Qiu E. Yang, Kirsty Sands, Eduardo A. Medeiros, Timothy R. Walsh, Ana C. Gales

Summary: This study describes the undetected outbreak of a rare carbapenemase BKC-1-producing Klebsiella pneumoniae ST442 clone, occurring in a Brazilian hospital. The misidentification of BKC-1 may have contributed to the spread of resistant clones, emphasizing the importance of correct and rapid identification of antimicrobial resistance mechanisms in hospitals.

INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2022)

添加到收藏夹

Article Infectious Diseases

Sequencing of fosA: A Rapid and Inexpensive Method for Discriminating Klebsiella pneumoniae CC258 from Other Clones

Aghata Cardoso da Silva Ribeiro, Fernanda Fernandes Santos, Ikechukwu Benjamin Moses, Luciene Andrade da Rocha Minarini, Ana Cristina Gales

Summary: In this study, a new fast, economic, and effective typing technique for carbapenem-resistant Klebsiella pneumoniae (CR-KPN) was explored by analyzing the fosA(KP) sequence. The results showed that chromosomal fosA(KP) sequences are highly conserved in different STs and CCs, providing a useful tool to identify the epidemiological STs for KPN and discriminate them from CC258/11.

MICROBIAL DRUG RESISTANCE (2022)

添加到收藏夹

Letter Infectious Diseases

Genome sequencing of an XDR Klebsiella pneumoniae ST101 strain isolated from a Brazilian Amazon river

Tiago Barcelos Valiatti, Fernanda Fernandes Santos, Andre Valencio, Rodrigo Cayo, Tania Aparecida Tardelli Gomes, Ana Cristina Gales

JOURNAL OF GLOBAL ANTIMICROBIAL RESISTANCE (2022)

添加到收藏夹

Article Infectious Diseases

In Vitro and In Vivo Synergism of Fosfomycin in Combination with Meropenem or Polymyxin B against KPC-2-Producing Klebsiella pneumoniae Clinical Isolates

Aghata Cardoso da Silva Ribeiro, Yohanna Carvalho dos Santos Aoun Chikhani, Tiago Barcelos Valiatti, Andre Valencio, Mariana Neri Lucas Kurihara, Fernanda Fernandes Santos, Luciene Andrade da Rocha Minarini, Ana Cristina Gales

Summary: In this study, the activity of fosfomycin in combination with meropenem or polymyxin B against KPC-KPN was evaluated. The results showed that the combination of fosfomycin and meropenem restored meropenem activity and exhibited a synergistic effect with fosfomycin and polymyxin B. In the Galleria mellonella model, the combination of fosfomycin and meropenem had a higher survival rate for larvae, while fosfomycin and polymyxin B combination had a more significant biofilm disruption effect.

ANTIBIOTICS-BASEL (2023)

添加到收藏夹

Article Microbiology

Antifungal Activity of Isavuconazole and Comparator Agents against Contemporaneous Mucorales Isolates from USA, Europe, and Asia-Pacific

Cecilia G. G. Carvalhaes, Paul R. R. Rhomberg, Michael D. D. Huband, Michael A. A. Pfaller, Mariana Castanheira

Summary: Isavuconazole is the only FDA-approved antifungal for treating invasive mucormycosis. A global collection of Mucorales isolates was evaluated, and it was found that Isavuconazole displayed good inhibitory activity against most isolates, although there was variation among different species.

JOURNAL OF FUNGI (2023)

添加到收藏夹

暂无数据

© Peeref 2019-2024. All rights reserved.